Annual D&A
$3.45 M
+$130.00 K+3.91%
31 December 2023
Summary:
Foghorn Therapeutics annual depreciation & amortization is currently $3.45 million, with the most recent change of +$130.00 thousand (+3.91%) on 31 December 2023. During the last 3 years, it has risen by +$2.12 million (+160.06%). FHTX annual D&A is now at all-time high.FHTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$733.00 K
-$58.00 K-7.33%
30 September 2024
Summary:
Foghorn Therapeutics quarterly depreciation & amortization is currently $733.00 thousand, with the most recent change of -$58.00 thousand (-7.33%) on 30 September 2024. Over the past year, it has dropped by -$131.00 thousand (-15.16%). FHTX quarterly D&A is now -16.32% below its all-time high of $876.00 thousand, reached on 30 June 2023.FHTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$3.21 M
-$131.00 K-3.92%
30 September 2024
Summary:
Foghorn Therapeutics TTM depreciation & amortization is currently $3.21 million, with the most recent change of -$131.00 thousand (-3.92%) on 30 September 2024. Over the past year, it has dropped by -$236.00 thousand (-6.85%). FHTX TTM D&A is now -6.95% below its all-time high of $3.45 million, reached on 31 December 2023.FHTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | -15.2% | -6.8% |
| 3 y3 years | +160.1% | -14.9% | +7.8% |
| 5 y5 years | +810.5% | - | - |
FHTX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +160.1% | -16.3% | at low | -7.0% | +7.8% |
| 5 y | 5 years | at high | +810.5% | -16.3% | +188.6% | -7.0% | +1159.2% |
| alltime | all time | at high | +810.5% | -16.3% | +188.6% | -7.0% | +1159.2% |
Foghorn Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $733.00 K(-7.3%) | $3.21 M(-3.9%) |
| June 2024 | - | $791.00 K(-5.3%) | $3.34 M(-2.5%) |
| Mar 2024 | - | $835.00 K(-2.0%) | $3.43 M(-0.7%) |
| Dec 2023 | $3.45 M(+3.9%) | $852.00 K(-1.4%) | $3.45 M(+0.1%) |
| Sept 2023 | - | $864.00 K(-1.4%) | $3.45 M(+0.6%) |
| June 2023 | - | $876.00 K(+2.0%) | $3.43 M(+1.7%) |
| Mar 2023 | - | $859.00 K(+1.3%) | $3.37 M(+1.4%) |
| Dec 2022 | $3.32 M | $848.00 K(+0.6%) | $3.32 M(+1.2%) |
| Sept 2022 | - | $843.00 K(+2.9%) | $3.28 M(-0.5%) |
| June 2022 | - | $819.00 K(+1.0%) | $3.30 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $811.00 K(+0.1%) | $3.27 M(+1.2%) |
| Dec 2021 | $3.23 M(+143.2%) | $810.00 K(-5.9%) | $3.23 M(+8.3%) |
| Sept 2021 | - | $861.00 K(+9.8%) | $2.98 M(+25.5%) |
| June 2021 | - | $784.00 K(+1.6%) | $2.37 M(+28.7%) |
| Mar 2021 | - | $772.00 K(+37.1%) | $1.84 M(+39.0%) |
| Dec 2020 | $1.33 M(+91.5%) | $563.00 K(+120.8%) | $1.33 M(+73.7%) |
| Sept 2020 | - | $255.00 K(+0.4%) | $764.00 K(+50.1%) |
| June 2020 | - | $254.00 K(-0.4%) | $509.00 K(+99.6%) |
| Mar 2020 | - | $255.00 K | $255.00 K |
| Dec 2019 | $693.00 K(+82.8%) | - | - |
| Dec 2018 | $379.00 K | - | - |
FAQ
- What is Foghorn Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual D&A year-on-year change?
- What is Foghorn Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly D&A year-on-year change?
- What is Foghorn Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Foghorn Therapeutics?
- What is Foghorn Therapeutics TTM D&A year-on-year change?
What is Foghorn Therapeutics annual depreciation & amortization?
The current annual D&A of FHTX is $3.45 M
What is the all time high annual D&A for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual depreciation & amortization is $3.45 M
What is Foghorn Therapeutics annual D&A year-on-year change?
Over the past year, FHTX annual depreciation & amortization has changed by +$130.00 K (+3.91%)
What is Foghorn Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of FHTX is $733.00 K
What is the all time high quarterly D&A for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly depreciation & amortization is $876.00 K
What is Foghorn Therapeutics quarterly D&A year-on-year change?
Over the past year, FHTX quarterly depreciation & amortization has changed by -$131.00 K (-15.16%)
What is Foghorn Therapeutics TTM depreciation & amortization?
The current TTM D&A of FHTX is $3.21 M
What is the all time high TTM D&A for Foghorn Therapeutics?
Foghorn Therapeutics all-time high TTM depreciation & amortization is $3.45 M
What is Foghorn Therapeutics TTM D&A year-on-year change?
Over the past year, FHTX TTM depreciation & amortization has changed by -$236.00 K (-6.85%)